Literature DB >> 14265213

[THE EFFECT OF HEPARIN ON THE WATER-ELECTROLYTE BALANCE].

K VALLENT, J FACHET.   

Abstract

Entities:  

Keywords:  17-KETOSTEROIDS; EDEMA; HEART FAILURE, CONGESTIVE; HEPARIN, THERAPEUTIC; PHOTOMETRY; POTASSIUM; SODIUM; URINE; WATER-ELECTROLYTE BALANCE

Mesh:

Substances:

Year:  1965        PMID: 14265213     DOI: 10.1007/BF02350865

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  6 in total

1.  Effect of aldosterone antagonist on in vitro production of aldosterone and corticosterone in rats.

Authors:  G W KITTINGER; B C WEXLER; B F MILLER
Journal:  Proc Soc Exp Biol Med       Date:  1960-11

2.  Effect of heparinoid and spirolactone on the renal excretion of sodium and aldosterone.

Authors:  V CEJKA; L de VRIES; J van DAATSELAAR; J G BORST; C L MAJOOR
Journal:  Lancet       Date:  1960-02-06       Impact factor: 79.321

3.  Excretion pattern and mechanism of diuresis induced by heparin.

Authors:  C L MAJOOR; R J SCHLATMANN; A P JANSEN; H PRENEN
Journal:  Clin Chim Acta       Date:  1960-07       Impact factor: 3.786

4.  The natriuretic action of heparin and some related substances.

Authors:  R J SCHLATMANN; H PRENEN; A P JANSEN; C L MAJOOR
Journal:  Lancet       Date:  1960-02-06       Impact factor: 79.321

5.  Serum lipids and lipoproteins in diabetic glomerulosclerosis; preliminary observations of the effect of heparin upon the disease.

Authors:  H ENGELBERG; J GOFMAN; H JONES
Journal:  Diabetes       Date:  1952 Nov-Dec       Impact factor: 9.461

6.  Normal urinary excretion of neutral 17-ketosteroids with special reference to age and sex variations.

Authors:  C HAMBURGER
Journal:  Acta Endocrinol (Copenh)       Date:  1948
  6 in total
  1 in total

1.  The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man.

Authors:  E C Abbott; A G Gornall; D J Sutherland; J C Laidlaw; M Stiefel
Journal:  Can Med Assoc J       Date:  1966-05-28       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.